Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-World Crisaborole Use in Pediatric Atopic Dermatitis in Thailand
TCTR20230421004Completed
- Sponsor
- Pfizer
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of crisaborole in atopic dermatitis (AD), sponsored by Pfizer. Started Aug 2023; status: completed.
02
Drugs
crisaborole
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on TCTR20230421004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230421004.